Leading independent directors and influential institutional investors propose a new approach to shareholder-director engagement.
Christopher Cox recognized for his work advising Elan, which included the sale of Elan’s 50 percent stake in multiple sclerosis drug Tysabri.
Antitrust team recognized with GCR's 2014 "Matter of the Year" and "Merger Control Matter of the Year - Europe" awards.
Corporate Partner Christopher Cox led the Cadwalader team in this transaction that combined Perrigo and Elan under a new company incorporated in Ireland called Perrigo Company plc.
Cadwalader wins Financial Regulation Team of the Year and Restructuring Deal of the Year honors at 2014 IFLR Americas Awards.
Brad Bondi, head of the firm’s Securities Enforcement & Investigations Practice, was named among "the best of the first generation of global investigations lawyers" by Global Investigations Review.
Global energy-trading company makes $3.5 billion purchase.
The firm is ranked number one in deal value as both issuer’s counsel and underwriter’s counsel in the Mortgage-Backed Securities category.